Skip to Main Content

Paper Details

Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems.
Annual Review of Pharmacology and Toxicology
69
2018
Human, Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells, cardiotoxicity, hiPSC, hiPSC-CMs, human, human cardiomyocytes, human induced pluripotent stem cell-derived cardiomyocytes, patient
Author NameAffiliation
Daniel BernsteinStanford Cardiovascular Institute, Stanford University School of Medicine
Daniel BernsteinStanford University School of Medicine
  • 1 - 2

Datasets

Release 1.2